Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Adaptimmune Therapeutics (ADAP) SEC Filings & 10K Form

Adaptimmune Therapeutics logo
$0.07 +0.01 (+15.41%)
Closing price 04:00 PM Eastern
Extended Trading
$0.07 0.00 (-0.87%)
As of 05:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Adaptimmune Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/19/2025
6:07 PM		Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2025
5:53 PM		Adaptimmune Therapeutics (Subject)
New Enterprise Associates 14, L.P. (Filed by)
Form SCHEDULE 13D/A
08/19/2025
5:32 PM		Adaptimmune Therapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
Form SCHEDULE 13G/A
08/15/2025
3:30 PM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2025
4:43 PM		Adaptimmune Therapeutics (Subject)
Two Seas Capital LP (Filed by)
Form SCHEDULE 13G/A
08/13/2025
6:47 AM		Adaptimmune Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2025
6:37 AM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2025
5:20 PM		Adaptimmune Therapeutics (Issuer)
EcoR1 Capital, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2025
6:37 AM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2025
3:30 PM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
6:35 AM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
3:15 PM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
7:02 AM		Adaptimmune Therapeutics (Filer)
Form DEF 14A
04/15/2025
7:00 AM		Adaptimmune Therapeutics (Filer)
Form PRE 14A
04/14/2025
3:10 PM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
3:40 PM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
3:44 PM		Adaptimmune Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2025
6:09 AM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
4:34 PM		Adaptimmune Therapeutics (Issuer)
Brewer Joanna Elizabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:35 PM		Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:30 PM		Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:31 PM		Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:32 PM		Adaptimmune Therapeutics (Issuer)
Piccina Cintia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:33 PM		Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
8:31 AM		Adaptimmune Therapeutics (Subject)
Two Seas Capital LP (Filed by)
Form SCHEDULE 13G
02/12/2025
9:25 AM		Adaptimmune Therapeutics (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SCHEDULE 13G/A
01/17/2025
8:15 PM		Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
8:16 PM		Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
8:17 PM		Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
8:17 PM		Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
2:07 PM		Adaptimmune Therapeutics (Subject)
Norry Elliot (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
1:42 PM		Adaptimmune Therapeutics (Subject)
Rawcliffe Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
1:50 PM		Adaptimmune Therapeutics (Subject)
Bertrand William C JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
1:59 PM		Adaptimmune Therapeutics (Subject)
Lunger John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:15 PM		Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:16 PM		Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:17 PM		Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:18 PM		Adaptimmune Therapeutics (Issuer)
Piccina Cintia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:19 PM		Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
2:43 PM		Adaptimmune Therapeutics (Subject)
Lunger John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
2:50 PM		Adaptimmune Therapeutics (Subject)
Norry Elliot (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel

All the details are waiting for you now — but you need to act before the September 1st funding windo
01/15/2025
2:34 PM		Adaptimmune Therapeutics (Subject)
Rawcliffe Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
9:30 AM		Adaptimmune Therapeutics (Subject)
Matrix Capital Management Company, LP (Filed by)
Form SCHEDULE 13G/A
12/19/2024
6:40 AM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
4:17 PM		Adaptimmune Therapeutics (Subject)
Matrix Capital Management Company, LP (Filed by)
Form SCHEDULE 13G/A
11/13/2024
8:04 AM		Adaptimmune Therapeutics (Subject)
Matrix Capital Management Company, LP (Filed by)
Form SC 13G/A
11/13/2024
8:10 AM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:00 PM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:15 PM		Adaptimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ADAP) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsoredtc pixel
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
The stealth altcoin the financial world is underestimating
This DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...
Crypto 101 Media | Sponsoredtc pixel
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
What Are Some Strategies to Help Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...
SmartAsset | Sponsoredtc pixel